Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando C Fervenza

Showing results (21-30 of 350) with videos related to

Pageof 35
Sort By:
Nature Reviews. Nephrology|January 14, 2015
Glomerular disease in 2014: advances in basic science and translational medicineFernando C Fervenza, Sanjeev Sethi
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 21, 2018
Standardized classification and reporting of glomerulonephritisSanjeev Sethi, Fernando C Fervenza
Clinical Kidney Journal|November 6, 2024
Why laser microdissection and mass spectrometry is the method of choice for detection of membranous nephropathy antigensSanjeev Sethi, Fernando C Fervenza
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 8, 2022
Dendrin in IgA nephropathy: protective or marker of early disease?Rosanna Coppo, Fernando C Fervenza
The New England Journal of Medicine|December 3, 2025
Pegcetacoplan for Treatment of C3 Glomerulopathy and Immune-Complex MPGNLadan Zand, Fernando C Fervenza
Seminars in Nephrology|August 16, 2011
Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classificationSanjeev Sethi, Fernando C Fervenza
Clinical Journal of the American Society of Nephrology : CJASN|October 25, 2014
Circulating complement levels and C3 glomerulopathyFernando C Fervenza, Sanjeev Sethi
Mayo Clinic Proceedings|December 3, 2008
71-year-old man with shortness of breath and rashSaugar Maripuri, Fernando C Fervenza
Kidney International Reports|January 10, 2022
"Presumed" Primary Focal Segmental Glomerulosclerosis: A Novel Nuance for Steroid TherapyRichard J Glassock, Fernando C Fervenza
Kidney360|April 4, 2022
Kidney Biopsy Is Required for Nephrotic Syndrome with PLA2R+ and Normal Kidney Function: The Con ViewShane A Bobart, Fernando C Fervenza
Pageof 35

Showing results (21-30 of 350) with videos related to

Sort By:
Pageof 35
Nature Reviews. Nephrology|January 14, 2015
Glomerular disease in 2014: advances in basic science and translational medicineFernando C Fervenza, Sanjeev Sethi
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 21, 2018
Standardized classification and reporting of glomerulonephritisSanjeev Sethi, Fernando C Fervenza
Clinical Kidney Journal|November 6, 2024
Why laser microdissection and mass spectrometry is the method of choice for detection of membranous nephropathy antigensSanjeev Sethi, Fernando C Fervenza
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 8, 2022
Dendrin in IgA nephropathy: protective or marker of early disease?Rosanna Coppo, Fernando C Fervenza
The New England Journal of Medicine|December 3, 2025
Pegcetacoplan for Treatment of C3 Glomerulopathy and Immune-Complex MPGNLadan Zand, Fernando C Fervenza
Seminars in Nephrology|August 16, 2011
Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classificationSanjeev Sethi, Fernando C Fervenza
Clinical Journal of the American Society of Nephrology : CJASN|October 25, 2014
Circulating complement levels and C3 glomerulopathyFernando C Fervenza, Sanjeev Sethi
Mayo Clinic Proceedings|December 3, 2008
71-year-old man with shortness of breath and rashSaugar Maripuri, Fernando C Fervenza
Kidney International Reports|January 10, 2022
"Presumed" Primary Focal Segmental Glomerulosclerosis: A Novel Nuance for Steroid TherapyRichard J Glassock, Fernando C Fervenza
Kidney360|April 4, 2022
Kidney Biopsy Is Required for Nephrotic Syndrome with PLA2R+ and Normal Kidney Function: The Con ViewShane A Bobart, Fernando C Fervenza
Pageof 35